What People Mean by Ozempic Face
Medically reviewed by
4 independent reviewers
Andrew Conrad Barile, kinésithérapeute, DPT
Doctorat en physiothérapie (DPT), physiothérapeute agréé (PT)
Read bio
Le Dr Andrew Conrad Barile est docteur en physiothérapie et PDG ainsi que fondateur de Xtreem Pulse LLC. Il a obtenu son doctorat en physiothérapie à Daemen College et possède plus de vingt ans d'expérience clinique et entrepreneuriale en physiothérapie pédiatrique, thérapie craniosacrale et innovation en dispositifs médicaux. Sa profonde connaissance de l'anatomie humaine, de la physiologie musculaire et des technologies thérapeutiques offre une approche scientifique précieuse pour le rajeunissement du visage et les solutions anti-âge.
Bertica M. Rubio, M.D.
Directeur Médical, Clinique de Médecine Régénérative Anti-âge | Médecin Certifié par le Conseil | École de Médecine de Dartmouth
Read bio
Le Dr Bertica M. Rubio est une médecin certifiée et directrice médicale de la clinique de médecine régénérative anti-âge à Redlands, en Californie. Elle a obtenu son Bachelor of Science à l'Université Loyola Marymount et son Doctorat en médecine à la Dartmouth Medical School (Geisel School of Medicine). Elle a effectué sa résidence en pédiatrie au UC Irvine Medical Center.
Forte de plusieurs décennies d'expérience clinique, le Dr Rubio est spécialisée en médecine de gestion du vieillissement, médecine régénérative, cicatrisation des plaies et thérapies par facteurs de croissance. Sa pratique intègre la science médicale fondée sur des preuves avec des traitements esthétiques et régénératifs avancés, aidant les patients à atteindre une santé optimale et une vitalité juvénile.
Le Dr Rubio est passionnée par l'éducation des patients sur la science derrière les soins de la peau, le rajeunissement du visage et les technologies non invasives comme l'EMS (stimulation électrique musculaire) pour le tonus facial. Ses articles pour PureLift LAB allient connaissances médicales rigoureuses et conseils pratiques pour obtenir des résultats réels et durables.
Daniel Grinberg, MD, FACS
Otolaryngologiste et chirurgien de la tête et du cou certifié par le conseil | Membre, American College of Surgeons | Professeur clinique adjoint, Mount Sinai School of Medicine
Read bio
Daniel Grinberg, MD, FACS, est un oto-rhino-laryngologiste certifié par le conseil et chirurgien de la tête et du cou chez ENT and Allergy Associates à West Nyack, NY. Il a obtenu son diplôme de médecine au Columbia University College of Physicians and Surgeons, a effectué sa résidence en oto-rhino-laryngologie au New York University Medical Center, et est professeur clinique adjoint à la Mount Sinai School of Medicine. Il est membre de l'American College of Surgeons et de l'American Academy of Otolaryngology.
La perspective chirurgicale de la tête et du cou du Dr Grinberg offre aux lecteurs de PureLift LAB une vision clinique élargie — reliant la pratique EMS à domicile à l'anatomie médicale sous-jacente avec la même rigueur scientifique que celle que nous appliquons à chaque spécification d'appareil.
Prof. Dr med Ivo Buschmann
Président d'Angiologie, Hochschule Medizinische Brandenburg | Directeur de clinique, Clinique universitaire d'angiologie, Hôpital universitaire de Brandebourg | Ancien consultant principal, Charité Universitätsmedizin Berlin
Read bio
Le Prof. Dr. med. Ivo Buschmann est titulaire de la chaire d'angiologie à la Medizinische Hochschule Brandenburg Theodor Fontane (MHB) et directeur de la clinique universitaire d'angiologie à l'hôpital universitaire de Brandebourg. Il a effectué sa formation médicale à l'Université de Hambourg, a été boursier de la Société Max-Planck à l'Institut Max-Planck de recherche sur le cœur et les poumons, et a occupé des postes de consultant principal à la Charité Universitätsmedizin Berlin Campus Virchow avant d'être nommé titulaire de la chaire à la MHB en 2016.
Le Prof. Buschmann est l'une des principales autorités européennes en arteriogenèse — la croissance et le remodelage des vaisseaux sanguins induits par le flux — avec plus de 150 publications évaluées par des pairs et plusieurs brevets américains et européens sur des dispositifs stimulant la croissance des vaisseaux collatéraux par une thérapie contrôlée du taux de cisaillement. Ses recherches relient la stimulation mécanique et électrique à l'adaptation vasculaire, à la microcirculation et à la perfusion tissulaire.
Les contributions du Prof. Buschmann apportent aux lecteurs de PureLift LAB une perspective en biologie vasculaire qui complète notre expertise clinique, en physiothérapie et en anatomie chirurgicale — expliquant comment la stimulation EMS engage non seulement les muscles faciaux mais aussi la microcirculation qui les alimente, et pourquoi une administration intelligente est aussi importante au niveau du flux sanguin qu'à celui de la contraction musculaire.
Partager
Ozempic face is a media term rather than a medical one, and what it describes is the hollow look that follows rapid weight loss by any route.
This article covers what actually decides the answer, such as:
- Where the term came from
- Why the face shows it first
- Rate matters more than route
- What does not fix it
- What does
and many more!
That matters because it tells you which intervention addresses it, and the answer is volume replacement rather than anything sold for home use.
Key Points:
Facial fat sits in discrete compartments, so loss is uneven and reads as hollow in one place and slack in another.
Losing weight faster produces a more abrupt facial change than losing it slowly.
No electrical device, cream or light replaces fat.
The rate of loss and protein intake are prescriber questions, and they affect the face more than any product does.
Fillers are the intervention that addresses volume, and that is a clinical decision.
Where the term came from
A dermatologist's observation, picked up by the press, that patients losing weight quickly on GLP-1 medication were arriving with a gaunter face. The observation was accurate and the label stuck.
What the label obscures is that nothing about the medication targets the face. The same appearance followed very low calorie diets, illness and bariatric surgery decades before, and it follows any fast loss of body fat.
So the useful question is not what the drug does to skin; it is what losing facial fat quickly does to a face.
Why the face shows it first
Facial fat is not an even layer. It sits in discrete compartments, and those compartments give the cheek its fullness and the midface its shape.
When body fat falls, the facial compartments go with it, and because they are small, a proportionally modest loss is highly visible. The upper compartments tend to empty while the lower ones hold on, which produces a hollow upper cheek and a heavier lower face at the same time.
Skin that had been filled out does not always retract at the same rate, particularly at older ages, so there is a period where the volume has gone and the covering has not adjusted.
And reduced volume changes how light falls across the face, which exaggerates the impression beyond the actual change.
Rate matters more than route
Losing the same amount slowly gives skin and tissue more time to adjust than losing it in three months does. That is the part of this within anyone's influence, and it is a conversation for the clinician managing your treatment.
Rapid loss by any route can also involve losing lean tissue alongside fat, and how to manage that, through protein intake, resistance training or the pace itself, is a clinical question with real answers.
It is also the question most likely to affect how your face looks, and it is not one a facial device brand is qualified to answer. Raise it at your next appointment rather than working around it with products.
What does not fix it
Creams do not replace volume, because volume is fat and no topical creates fat.
Electrical stimulation does not either. EMS works muscle, which is a different tissue in a different layer, and a device page implying it restores facial fullness is selling you something.
Heat-based treatments target the dermis and address laxity rather than volume, so they answer a different part of the picture if skin quality is also a concern.
What does
Fillers replace volume directly, and that is what they are for. Placement, product and amount are clinical decisions, and a consultation will tell you more than any article about whether it is the right answer for your face.
Fat transfer is the other route, using your own tissue, and is a surgical decision.
Both belong with a qualified clinician rather than in a shopping basket.
Where a device honestly fits
Muscle tone, which is a real part of the structure holding the midface up and is not the part that emptied.
Kavanagh and colleagues measured an 18.6 percent increase in cheek muscle thickness over 12 weeks of motor-level facial stimulation across 108 women (10.1111/jocd.12007), which is category evidence rather than a trial in anyone losing weight; nobody has studied facial stimulation during GLP-1 treatment.
Better support under a face that has lost volume is a modest and real thing to want. It is not a substitute for the volume and we would rather say that than take advantage of a moment when people feel bad about how they look.
For what a device can and cannot do during weight loss specifically, see facial changes during GLP-1 weight loss, and for the layer map, the six layers of the face.
This is general information about facial structure and is not medical advice. Questions about your medication, your rate of weight loss, or your nutrition belong with the clinician managing your treatment.
Two related questions come up often alongside this one, and we have answered both in full: whether facial stimulation affects facial fat, which nobody has measured, and what microcurrent does and does not do for jowls.